Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H5N1 Influenza Vaccine in Children and Adolescents
NCT00537524Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2007
- Primary completion
- Oct 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of inactivated Vero cell based whole virus influenza A/H5N1 in Avian Influenza (AI), sponsored by Novartis. Started Sep 2007; status: completed.
02
Drugs
inactivated Vero cell based whole virus influenza A/H5N1
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on NCT00537524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537524.